Episode 18: Karen Petrou and David Brint

Few & Far Between: Conversations from the Front Lines of Drug Development

Episode 18: Karen Petrou and David Brint - BioBonds

Mar 23 2022 | 00:55:46

00:00 / 00:55:46

Show Notes

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

Other Episodes

Episode 33

September 20, 2023 • 00:26:33

Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals

Episode 54

May 28, 2025 • 00:45:11

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between...

Episode 14

November 10, 2021 • 00:46:16

Episode 14: Bo Bigelow, Chairman at the Foundation for USP7-Related Diseases, and Trish Flanagan, President at the Yellow Brick Road Project

How will a rare disease diagnosis affect your family? Today's Few & Far Between episode features Bo Bigelow, Chairman at the Foundation for USP7-Related...